Personal Peptides Speeds Genomic Analytics with Optimized AWS Infrastructure

4 Pages

Personal Peptides Speeds Genomic Analytics with Optimized AWS Infrastructure Case Study Flux7, an NTT DATA Company | All Rights Reserved | www.flux7.com | 844.FLUX700 Personal Peptides Speeds Genomic Analytics with Optimized AWS Infrastructure Flux7, an NTT DATA Company | All Rights Reserved | www.flux7.com | 844.FLUX700 Profile: Founded in Houston, Texas, Personal Peptides is the first company to develop a nutrigenomic tool for cancer patients, designed to improve their cancer-specific immune system. By bridging the gap between the human immune system and personal genomics, Personal Peptides aims to provide individuals with the tools to sculpt their own immune repertoires. Challenge: Secure compliant HPC framework to bring the solution to market. ? Personal Peptides

Join for free to read

Ebook Accelerate AI innovation with AWS infrastructure

Case Study Hassan Allam Pioneers Digital Growth in Egypt with AWS

Case Study AWS Glue drives faster data ingestion pipeline

Ebook OpenText Core Analytics Database

More from Flux7

Case Study Optimized AWS Infrastructure Helps LegalZoom to Scale Securely

Case Study Pharma Giant Migrates R&D Analytics to AWS

Case Study Web Developer Grows Performance, Elasticity, and Security…

Case Study Leader in Healthcare Systems Grows Uptime and Security with…

Case Study

Personal Peptides Speeds Genomic Analytics with Optimized AWS Infrastructure

Personal Peptides Speeds Genomic Analytics with Optimized AWS Infrastructure

You Might Also Like

More from Flux7